Quarterly revenue of $735 million;GAAP loss of ($4.90)/share and adjusted EPS of $0.75DALLAS, Feb. 20, 2025 (GLOBE NEWSWIRE) -- AMN Healthcare ...
Many, including prominent scientists, seem to misunderstand the true cost of biomedical research and the fact that ...
Q4 2024 performance with robust EBITDA gains, 2025 growth outlook, specialty market expansion, & free cash flow improvements.
From hiring freezes to spending cuts, research universities are trying to manage their finances amid a fluid and harrowing ...